5-Methyl-1H-pyrazole-3-carboxylic acid
| Title | Journal |
|---|---|
| Alterations in extracellular tryptophan and dopamine concentrations in rat striatum following peripheral administration of D- and L-tryptophan: an in vivo microdialysis study. | Neuroscience letters 20120920 |
| Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone. | Indian journal of pharmacology 20120101 |
| Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan. | Proceedings of the Japan Academy. Series B, Physical and biological sciences 20111209 |
| Fluorescence determination of D- and L-tryptophan concentrations in rat plasma following administration of tryptophan enantiomers using HPLC with pre-column derivatization. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111101 |
| A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. | The Journal of pharmacology and experimental therapeutics 20110101 |
| Comparative study on kynurenic acid production in the rat striatum by tryptophan enantiomers: an in vivo microdialysis study. | Chirality 20110101 |
| Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers. | Chirality 20101101 |
| Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study. | Neurochemical research 20100401 |
| The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. | The open medicinal chemistry journal 20100101 |
| Aqua-[2-(5-ethyl-2-pyridyl-κN)-4-iso-propyl-4-methyl-5-oxo-4,5-dihydroxy-imidazol-1-ido-κN](5-methyl-1H-pyrazole-3-carboxyl-ato-κN,O)copper(II) 1.33-hydrate. | Acta crystallographica. Section E, Structure reports online 20100101 |
| Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. | Biochemical pharmacology 20091201 |
| Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors. | Journal of medicinal chemistry 20090611 |
| Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers. | Chirality 20090401 |
| Diaqua-(5-methyl-1H-pyrazole-3-carboxyl-ato)(4-nitro-benzoato)copper(II). | Acta crystallographica. Section E, Structure reports online 20090201 |
| Does nicotinic acid (niacin) lower blood pressure? | International journal of clinical practice 20090101 |
| In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080301 |
| Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. | Bioorganic & medicinal chemistry letters 20071015 |
| Agonist lead identification for the high affinity niacin receptor GPR109a. | Bioorganic & medicinal chemistry letters 20070901 |
| Nicotinic acid receptor agonists differentially activate downstream effectors. | The Journal of biological chemistry 20070622 |